Symbiotec Pharmalab IPO Allotment Status: How to Check, Final Subscription, and Listing Timeline

The Symbiotec Pharmalab IPO allotment is expected to be finalised on 28 August 2026. Investors who applied for the ₹1,757.30 crore book-built mainboard IPO should use MUFG Intime India Private Limited’s website as the primary channel to check allotment status, with the BSE and NSE application-status pages as additional verification routes.

The issue received a strong response, with the final overall subscription reported at about 71.19 times. Qualified institutional buyers led participation at about 172.03 times, non-institutional investors subscribed about 73.61 times, retail individual investors about 12.84 times, and the employee category about 15.29 times. The unofficial grey market premium (GMP) was ₹260 per share, or about 26.3% over the upper issue price of ₹988, as of the afternoon (2:00 p.m. to 3:30 p.m. IST) on 27 August 2026, suggesting positive unofficial sentiment.

Symbiotec Pharmalab IPO Allotment Status: Latest Update

Symbiotec Pharmalab Limited closed its IPO for bidding on 27 August 2026, and the basis of allotment is scheduled for 28 August 2026. At this stage, allotment should be treated as expected, not finalised, until the registrar processes the basis of allotment and the result becomes searchable.

MUFG Intime India Private Limited is the registrar. Applicants should therefore rely first on the registrar’s allotment facility rather than treating an approved Unified Payments Interface (UPI) mandate, a successful bid record, or a broker-app status as proof of allotment.

Symbiotec Pharmalab IPO Allotment and Listing Timeline

Event	Date	What it means
IPO closed	27 August 2026	Fresh applications and bid changes ended
Basis of allotment	28 August 2026	Allocation is expected to be finalised
Debit or fund unblocking	31 August 2026	Payable funds may be debited and excess or unsuccessful application blocks released
Demat credit	31 August 2026	Allotted shares are expected to reach eligible demat accounts
Listing	1 September 2026	Shares are scheduled to begin trading on BSE and NSE

These dates reflect the latest available issue schedule. Applicants should focus on the registrar result once allotment is finalised, then monitor their bank and demat accounts for the subsequent processing steps.

What You Need to Check the Allotment

Keep the identifier used with your IPO application ready. The registrar facility supports details including:

• Permanent Account Number (PAN)
• IPO application number
• Depository Participant (DP) ID and Client ID
• Bank account and Indian Financial System Code (IFSC) details where supported

Checking an allotment result should not require your UPI PIN, bank password, trading password, or demat password.

How to Check Symbiotec Pharmalab IPO Allotment Status

Check on the Official Registrar Website

The registrar is the primary source because it processes the basis of allotment and applicant-level records.

1. Open the MUFG Intime IPO allotment-status page.
2. Select Symbiotec Pharmalab Limited when it becomes available in the company list.
3. Choose an available identifier, such as PAN, application number, or DP/Client ID.
4. Enter the requested details carefully.
5. Complete any verification shown on the page.
6. Submit the request and review the displayed allotment result.

If the issue is not yet available in the dropdown, that does not by itself mean the application was unsuccessful. The registrar may still be loading or processing the allotment data.

Check on BSE

Applicants can also use the BSE IPO application-status facility.

Select the relevant issue, enter the required application details, and submit the form. The BSE route is useful as an additional verification method, but applicants should continue to treat the registrar as the primary allotment source.

Check on NSE

The NSE IPO bid and allotment verification page allows investors to select the IPO symbol and search using PAN or an application number.

NSE distinguishes bid verification from allotment information. A bid record confirms that application details reached the exchange bidding system. It does not, by itself, prove that shares were allotted. Allotment information appears after the registrar supplies the relevant allocation data.

What Does Your IPO Allotment Status Mean?

Status	Meaning	What to do
Allotted	Shares have been allocated to your application	Check the allotted quantity and monitor the demat credit
Not allotted	No shares were allocated	Monitor release of the blocked application amount
Pending or under process	Processing is not complete	Check again after the registrar updates its records
No record found	The system cannot match the submitted details	Recheck the issue name and identifiers before assuming rejection

A “no record found” message can result from an incorrect PAN or application number, the wrong issue selection, delayed data loading, or an application-record problem.

Symbiotec Pharmalab IPO Final Subscription

The final bidding data showed substantial oversubscription across all major applicant groups.

Investor category	Final subscription
Qualified institutional buyers (QIBs)	172.03 times
Non-institutional investors (NIIs)	73.61 times
Retail individual investors (RIIs)	12.84 times
Employees	15.29 times
Overall	71.19 times

For a retail applicant, the 12.84-times retail subscription is more relevant than the 71.19-times headline figure when understanding demand within the retail pool.

However, subscription does not translate directly into a “one in X” allotment probability. The final outcome depends on valid applications, the basis of allotment, applicable allocation rules, and the number of eligible applications. An exact allotment chance should not be claimed without the final basis-of-allotment data.

What Happens After IPO Allotment?

If Shares Are Allotted

Under the Application Supported by Blocked Amount (ASBA) process, the amount payable for allotted shares is debited from the blocked application funds. Any excess blocked amount is released.

The allotted shares are then expected to be credited to the applicant’s demat account on 31 August 2026. Check that the quantity credited matches the final allotment shown by the registrar.

If Shares Are Not Allotted

If no shares are allotted, the blocked application amount should be released rather than treated as a separate fresh payment or conventional refund.

The bank account may not display the release immediately. Processing and account-display times can vary even after the unblock instruction has been initiated.

Allotment Not Showing or Funds Still Blocked?

First, confirm that the allotment has actually been finalised before treating a missing result as a problem. If the record should already be available:

• Recheck the PAN, application number, DP ID, and Client ID.
• Confirm that the correct IPO has been selected.
• Verify that the application was successfully captured.
• Remember that an approved UPI mandate confirms fund blocking, not share allotment.
• Possible application problems can include a PAN mismatch, duplicate application, unsuccessful mandate, or invalid third-party payment details.

For allotment-result problems, contact the registrar. For funds that remain blocked after the expected release process, contact your bank or self-certified syndicate bank. For an incorrect application number or an order-routing discrepancy, contact the broker through which the application was placed.

Bottom Line

Symbiotec Pharmalab IPO allotment is expected to be finalised on 28 August 2026, with MUFG Intime India Private Limited serving as the primary status-checking channel. Applicants should verify the registrar result first, then monitor fund debit or unblocking and demat credit ahead of the scheduled 1 September 2026 listing.

Frequently Asked Questions (FAQs)